+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sangamo Therapeutics Inc - logo

Sangamo BioSciences is a biotechnology company that develops industry leading technologies in gene therapy, genome editing, cell therapy and gene regulation. The company is focused on pioneering genetic cures for monogenic and infectious diseases by deploying its AAV-based gene therapy platform, and therapeutic genome editing and gene regulation platforms based on its novel zinc finger DNA-binding protein technology. Sangamo is headquartered in Richmond, California.

From
From
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • April 2026
  • 182 Pages
  • Global
From
From
Hemophilia Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 476 Pages
  • Global
From
From
From
From
Sickle Cell Disease Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Sickle Cell Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 188 Pages
  • Global
From
From
Sickle Cell Treatment Market - Global Forecast to 2030 - Product Thumbnail Image

Sickle Cell Treatment Market - Global Forecast to 2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Hemophilia Market Report 2026 - Product Thumbnail Image

Hemophilia Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Sickle Cell Disease Treatment Market Report 2026 - Product Thumbnail Image

Sickle Cell Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Loading Indicator